Asthma treatment: Cipla gets final approval from USFDA for Albuterol Sulfate Inhalation Aerosol
We are pleased to receive the final approval for generic Albuterol MDI from the USFDA. This further strengthens our presence in the US market. This development reiterates our commitment of strengthening our respiratory franchise and will further solidify our position as lung leader globally.
Cipla Ltd on Thursday said it has received final approval from the US health regulator, Photo: Reuters